Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 71 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Aptamer-controlled Stimuli-Responsive Drug Release
Xingxing Peng,Yanfei Liu, Feicheng Peng,Ting Wang, Zhongyu Cheng, Qiwen Chen, Mingfeng Li, Lishang Xu, Yunqi Man, Zhirou Zhang,Yifu Tan,Zhenbao Liu
International journal of biological macromoleculesno. Pt 3 (2024): 135353-135353
Cited0Views0WOSBibtex
0
0
DNA Nanostructures: Advancing Cancer Immunotherapy
Qianqian Chen, Yanfei Liu, Qiwen Chen, Mingfeng Li, Lishang Xu, Bingyu Lin, Yifu Tan,Zhenbao Liu
Small (Weinheim an der Bergstrasse, Germany)pp.e2405231-e2405231, (2024)
Cited0Views0WOSBibtex
0
0
Carrier Cascade Target Delivery of 5-Aminolevulinic Acid Nanoplatform to Enhance Antitumor Efficiency of Photodynamic Therapy Against Lung Cancer
Ze Li, Yuxuan Song, Qiang Luo,Zhenbao Liu, Yunqi Man,Jianhua Liu, Yuze Lu,Liqing Zheng
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2024)
Cited0Views0WOSBibtex
0
0
CRISPR/Cas9 Systems: Delivery Technologies and Biomedical Applications
Yimin Dua,Yanfei Liu,Jiaxin Hu,Xingxing Peng,Zhenbao Liu
Asian Journal of Pharmaceutical Sciencespp.3-33, (2023)
Cited0Views0Bibtex
0
0
DNA-directed assembly of nanomaterials and their biomedical applications
Ke Li,Yanfei Liu,Beibei Lou,Yifu Tan,Liwei Chen,Zhenbao Liu
International Journal of Biological Macromolecules (2023): 125551-125551
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 70

#Citation: 1954

H-Index: 21

G-Index: 44

Sociability: 5

Diversity: 0

Activity: 2

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn